Debra E. Weese-Mayer, MD, the Beatrice Cummings Mayer Professor of Pediatric Autonomic Medicine at Feinberg and Chief of the Center for Autonomic Medicine in Pediatrics at Ann & Robert H. Lurie Children’s Hospital of Chicago, has been awarded the 2025 Paula H. Stern Award for Outstanding Women in Science and Medicine.
Northwestern Medicine investigators have discovered how proteins expressed in umbilical cord blood at birth evolve during gestational development and could serve as biomarkers to inform new precision care strategies for infants born prematurely, according to a recent study.
Many have posited the reason for rising mental health concerns among kids and teens – social media, the COVID-19 pandemic, stigma, etc. But the reality is there is a constellation of factors that contribute to this crisis, according to experts.
Tara O. Henderson, MD, MPH, has been named the Founders’ Board Centennial Chair of Pediatrics, effective March 31.
New research from scientists at Northwestern Medicine and Penn State describes PlacentaVision, a computer program that can analyze a simple photograph of the placenta to detect abnormalities associated with infection and neonatal sepsis.
Teens living in states requiring parental consent for mental health treatment may be less likely to access care, according to a Northwestern Medicine-led study published in JAMA Pediatrics.
New genetic variants have been linked to autism and developmental delays, according to an international study published in Molecular Psychiatry.
From 2008 to 2022, U.S. hospitals closed nearly 30 percent of pediatric inpatient units but only 4.4 percent of adult inpatient units, according to a recent Northwestern Medicine analysis published in JAMA Pediatrics.
Ten years after undergoing bariatric surgery as teens, over half of study participants demonstrated not only sustained weight loss, but also resolution of obesity-related conditions, such as type 2 diabetes, high blood pressure and high cholesterol.
Long-term treatment with the drug upadacitinib significantly improved symptoms and quality of life compared to placebo in adolescents with moderate to severe atopic dermatitis after 76 weeks with strong evidence of safety, according to a recent Northwestern Medicine analysis of three international, randomized clinical trials.